Inhibition by glucagon of the cGMP-inhibited low-Km cAMP phosphodiesterase in heart is mediated by a pertussis toxin-sensitive G-protein.

This publication has 23 references indexed in Scilit:

• G proteins in the heart. A redundant and diverse transmembrane signaling network.
  Circulation, 1991
• Hormonal Regulation of Cyclic Nucleotide Phosphodiesterases*
  Endocrine Reviews, 1991
• Cyclic AMP phosphodiesterases and Ca2+ current regulation in cardiac cells
  Life Sciences, 1991
• Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes
  Trends in Pharmacological Sciences, 1991
• Transduction of receptor signal into modulation of effector activity by G proteins: the first 20 years or so …
  The FASEB Journal, 1990
• Glucagon stimulates the cardiac Ca2+ current by activation of adenylyl cyclase and inhibition of phosphodiesterase
  Nature, 1990
• Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
  Trends in Pharmacological Sciences, 1990
• Role of G Proteins in the Regulation of the Cardiovascular System
  Annual Review of Physiology, 1989
• Cyclic guanosine 3',5'‐monophosphate regulates the calcium current in single cells from frog ventricle.
  The Journal of Physiology, 1987
• Responsiveness to glucagon in fetal hearts. Species variability and apparent disparities between changes in beating, adenylate cyclase activation, and cyclic AMP concentration.
  Journal of Clinical Investigation, 1976